VG Life Sciences Inc. BIOM

Annual Quarterly

FY2014 · ended Dec 31, 2014 · Revenue $0 · Filed Apr 15, 2015

VG Life Sciences Inc. (BIOM) files with the SEC under industry code 2834, Pharmaceutical Preparations. In fiscal 2014, which ended Dec 31, 2014, it reported revenue of $0 and a net loss of $6.2 million. Free cash flow was -$1.9 million.

Revenue (TTM)
$0
Net income (TTM)
$-4.30M
Operating cash flow (TTM)
$-858,336
Free cash flow
$-1.91M
EPS
—
Dividend per share
None
Shares outstanding
61.58M
Net cash
—
Operating margin
—

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
BIOM (OTC)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Miami, FL
SEC filer status
Smaller reporting company
SEC CIK
1091326
Former names
SB Technology Holdings, Inc. (until May 4, 2026); VG Life Sciences Inc. (until Mar 6, 2026); VG Life Sciences, Inc. (until Oct 14, 2014); VIRAL GENETICS INC /DE/ (until Mar 25, 2009); 5 STARLIVING ONLINE INC (until Oct 18, 2001)

Other Pharmaceutical Preparations companies

All 570 Pharmaceutical Preparations companies

Key figures

Fiscal-year totals from the annual reports. Balance sheet lines are as of each year end.

FY 2014
Dec 31, 2014
Revenue
$0
Operating income
-$4.1M
Net income
-$6.2M
Operating cash flow
-$1.9M
Free cash flow
-$1.9M
Total assets
$1.3M
Stockholders' equity
-$4.5M
Cash and investments
$33,992

Recent SEC filings

Form Description Filed Period
8-K Current report
Officer or director change
 Mar 30, 2016 Mar 29, 2016
10-Q Quarterly report Nov 19, 2015 Sep 30, 2015
10-Q Quarterly report Aug 19, 2015 Jun 30, 2015
8-K Current report
Material agreement
 May 21, 2015 May 21, 2015
10-Q Quarterly report May 20, 2015 Mar 31, 2015
8-K Current report
Agreement ended
 May 18, 2015 Mar 10, 2015

All 211 VG Life Sciences Inc. SEC filings

Source: SEC EDGAR filings. This is company-reported data, not investment advice.